Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade
Nature Medicine - In a retrospective analysis of patients with Lynch syndrome and primary cancers treated with immune checkpoint inhibitors, 12% developed subsequent malignancies, suggesting that...
nature.com